Market closed
Estrella Immunopharma Inc./$ESLA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
Ticker
$ESLA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
-
ISIN
US2975841048
Website
ESLA Metrics
BasicAdvanced
$35M
-
-$0.29
-
-
Price and volume
Market cap
$35M
52-week high
$1.25
52-week low
$0.73
Average daily volume
66K
Financial strength
Current ratio
0.221
Quick ratio
0.099
Management effectiveness
Valuation
Price to book
-19.21
Price to tangible book (TTM)
-19.21
Price to free cash flow (TTM)
-14.31
Growth
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Estrella Immunopharma Inc. stock?
Estrella Immunopharma Inc. (ESLA) has a market cap of $35M as of May 17, 2025.
What is the P/E ratio for Estrella Immunopharma Inc. stock?
The price to earnings (P/E) ratio for Estrella Immunopharma Inc. (ESLA) stock is 0 as of May 17, 2025.
Does Estrella Immunopharma Inc. stock pay dividends?
No, Estrella Immunopharma Inc. (ESLA) stock does not pay dividends to its shareholders as of May 17, 2025.
When is the next Estrella Immunopharma Inc. dividend payment date?
Estrella Immunopharma Inc. (ESLA) stock does not pay dividends to its shareholders.
What is the beta indicator for Estrella Immunopharma Inc.?
Estrella Immunopharma Inc. (ESLA) does not currently have a Beta indicator.